9 Meter Biopharma (NMTR) PT Raised to $5 at Oppenheimer
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- S&P 500 ends down; Apple dips ahead of quarterly report
- Apple beats quarterly estimates for profit and revenue
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
Tweet
Share
E-mailGet Alerts NMTR Hot Sheet
Price: $0.07 --0%
Rating Summary:
3 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 23 | Down: 26 | New: 23
Rating Summary:
3 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 23 | Down: 26 | New: 23
Join SI Premium – FREE
Oppenheimer analyst Francois Brisebois raised the price target on 9 Meter Biopharma (NASDAQ: NMTR) to $5.00 (from $4.00) while maintaining a Outperform rating.
You May Also Be Interested In
- BNP Paribas Exane Downgrades Randstad NV (RAND:NA) (RANJF) to Underperform
- Syrma SGS Technology (SYRMA:IN) PT Raised to INR1,560 at Kotak
- UPL Ltd. (UPLL:IN) PT Raised to INR580 at Kotak
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
